Deep Track Capital, LP: holdings and changes
Number 30 of the top 100 funds by copy return. Deep Track Capital, LP reported 71 US stocks worth $5.9B for the quarter ending 2026-09-30 and changed 18 new, 17 added, 16 trimmed and 13 sold since 2026-06-30.
Copy return, 4 quarters+55.6%
US 500, same time+14.5%
Size$5.9B
Stocks71
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| GH Guardant Health INC | TRIM -17% | 8.42% | $500M | 2,805,677 |
| BMRN Biomarin Pharmaceutical INC | ADD +93% | 6.44% | $382M | 6,374,395 |
| IMVT Immunovant INC | 5.21% | $310M | 9,160,801 | |
| TARS Tarsus Pharmaceuticals INC | ADD +4% | 5.04% | $299M | 3,806,768 |
| MANE Veradermics INC | TRIM -5% | 3.88% | $230M | 1,900,000 |
| VERA Vera Therapeutics INC | ADD +75% | 3.80% | $226M | 7,000,000 |
| PCVX Vaxcyte INC | TRIM -18% | 3.36% | $200M | 3,513,069 |
| ALKS Alkermes PLC | ADD +12% | 3.07% | $182M | 4,500,000 |
| OCUL Ocular Therapeutix INC | ADD +11% | 2.83% | $168M | 21,939,625 |
| UTHR United Therapeutics Corp | ADD +143% | 2.74% | $163M | 300,040 |
| GPCR Structure Therapeutics INC | ADD +5% | 2.63% | $156M | 5,000,000 |
| GRAL Grail INC | TRIM -40% | 2.60% | $155M | 1,104,200 |
| INSM Insmed INC. | BUY | 2.59% | $154M | 1,350,000 |
| CMPS Compass Pathways PLC | 2.55% | $151M | 12,161,496 | |
| GMAB Genmab A/S Sp Adr | TRIM -26% | 2.51% | $149M | 4,182,689 |
| AXSM Axsome Therapeutics INC | ADD +14% | 2.48% | $148M | 800,000 |
| NRIX Nurix Therapeutics INC | TRIM -22% | 2.39% | $142M | 6,000,000 |
| LBRX Lb Pharmaceuticals INC | 2.17% | $129M | 3,352,804 | |
| TNGX Tango Therapeutics INC | ADD +7% | 1.89% | $112M | 4,500,000 |
| MAZE Maze Therapeutics | ADD +9% | 1.87% | $111M | 4,083,969 |
| COAG Hemab Therapeutics Hldgs INC | 1.86% | $111M | 3,587,796 | |
| MLTX Moonlake Immunot | ADD +16% | 1.60% | $95M | 8,105,290 |
| ORKA Oruka Therapeutics INC | TRIM -44% | 1.50% | $89M | 1,069,774 |
| WGS Genedx Holdings | ADD +71% | 1.46% | $87M | 1,200,000 |
| COGT Cogent Biosciences INC | ADD +25% | 1.35% | $80M | 2,500,000 |
| GHRS Gh Research PLC | 1.32% | $78M | 3,333,334 | |
| BCAX Bicara Thera INC | 1.28% | $76M | 4,100,000 | |
| LTGO Latigo Biotherapeutics INC | BUY | 1.24% | $74M | 4,408,322 |
| CLDX Celldex Therapeutics INC | TRIM -28% | 1.16% | $69M | 2,125,532 |
| BBIO Bridgebio Pharma INC | BUY | 0.98% | $58M | 885,882 |
| AVTX Avalo Therapeutics INC | 0.93% | $55M | 3,610,000 | |
| ALMS Alumis INC | ADD +18% | 0.93% | $55M | 7,469,746 |
| ALT Altimmune INC | 0.93% | $55M | 19,250,000 | |
| ATTO Attovia Therapeutics INC | BUY | 0.93% | $55M | 3,207,138 |
| BLLN Billiontoone INC | BUY | 0.90% | $53M | 500,000 |
| ACRS Aclaris Therapeutics INC | 0.83% | $49M | 9,345,000 | |
| CRMD Cormedix INC | 0.81% | $48M | 6,274,076 | |
| EWTX Edgewise Therapeutics INC | BUY | 0.78% | $47M | 1,148,817 |
| VSTM Verastem INC | 0.78% | $46M | 5,740,850 | |
| DFTX Definium Therapeutics INC | TRIM -64% | 0.64% | $38M | 1,000,000 |
| GENB Generate Biomedicines INC | ADD +88% | 0.63% | $38M | 2,507,449 |
| MBX Mbx Biosciences INC | TRIM -63% | 0.63% | $38M | 640,000 |
| BIOSANTE PHARM Biosante Pharmaceuticals INC | BUY | 0.61% | $36M | 500,000 |
| VRDN Viridian Therapeutics INC | TRIM -52% | 0.59% | $35M | 1,711,030 |
| IMPRIMIS PHARM Imprimis Pharmaceuticals, INC. | ADD +10% | 0.55% | $33M | 1,069,000 |
| OBX Obsidian Therapeutics INC | BUY | 0.49% | $29M | 2,120,050 |
| CRVS Corvus Pharmaceuticals INC | 0.48% | $29M | 2,491,939 | |
| NBIX Neurocrine Biosciences INC | BUY | 0.48% | $28M | 200,000 |
| SLDB Solid Biosciences INC | 0.43% | $26M | 3,565,062 | |
| STTK Shattuck Labs INC | 0.43% | $25M | 3,706,734 | |
| BEAM Beam Therapeutics INC | 0.41% | $24M | 1,000,000 | |
| MNKD Mannkind Corp | TRIM -16% | 0.33% | $20M | 5,030,522 |
| XENE Xenon Pharmaceuticals INC | BUY | 0.31% | $19M | 500,000 |
| OLEMA PHARMACE Olema Pharmaceut | ADD +41% | 0.31% | $18M | 2,109,951 |
| NKTR Nektar Therapeutics | 0.31% | $18M | 300,000 | |
| DSGN Design Therapeutics INC | BUY | 0.28% | $17M | 1,323,986 |
| IPSC Century Therapeutics INC | 0.27% | $16M | 9,462,645 | |
| XNCR Xencor INC | TRIM -9% | 0.23% | $14M | 540,000 |
| MPLT Maplight Therapeutics INC | BUY | 0.23% | $13M | 1,318,101 |
| ENTA Enanta Pharmaceuticals INC | TRIM -31% | 0.22% | $13M | 1,000,000 |
| XFOR X4 Pharmaceuticals INC Com New | TRIM -23% | 0.22% | $13M | 4,501,684 |
| KARD Kardigan INC | 0.15% | $9M | 600,000 | |
| PMN Promis Neurosciences INC | TRIM -11% | 0.14% | $8M | 740,117 |
| ENTX Entera Bio LTD | BUY | 0.12% | $7M | 2,450,980 |
| RXST Rxsight INC | BUY | 0.10% | $6M | 1,230,566 |
| RNAQ Rainier Acquisition Corp | BUY | 0.09% | $5M | 500,000 |
| JTTT Jatt III Acquisition Corp | BUY | 0.08% | $5M | 450,000 |
| RACD Research Alliance Corp Iv | BUY | 0.08% | $5M | 400,000 |
| TCGX Tcgx Acquisition Corp | BUY | 0.06% | $4M | 300,000 |
| ALGS Aligos Therapeutics, INC. | 0.04% | $2M | 444,110 | |
| CNTX Context Therapeutics INC | 0.04% | $2M | 7,419,355 | |
| ALNY Alnylam Pharmaceuticals INC | SELL | 0% | was $248M | 0 |
| NUVALENT INC Nuvalent INC | SELL | 0% | was $220M | 0 |
| IONS Ionis Pharmaceuticals INC | SELL | 0% | was $174M | 0 |
| ATAI BECKLEY N Atai Beckley Nv | SELL | 0% | was $76M | 0 |
| CYTK Cytokinetics INC. | SELL | 0% | was $60M | 0 |
| PSNL Personalis INC | SELL | 0% | was $54M | 0 |
| DYN Dyne Therapeutics INC | SELL | 0% | was $33M | 0 |
| IMMX Immix Biopharma INC | SELL | 0% | was $29M | 0 |
| KURA Kura Oncology INC | SELL | 0% | was $22M | 0 |
| KLRA Kailera Therapeutics INC | SELL | 0% | was $15M | 0 |
| ELVN Enliven Therapeutics INC | SELL | 0% | was $11M | 0 |
| IMCR Immunocore Holdings Limited | SELL | 0% | was $10M | 0 |
| IVA Inventiva Sa | SELL | 0% | was $3M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-09-30 → 2023-12-31 | +12.9% | +11.2% |
| 2023-12-31 → 2024-03-31 | +0.2% | +10.0% |
| 2024-03-31 → 2024-06-30 | -0.9% | +4.0% |
| 2024-06-30 → 2024-09-30 | +9.0% | +5.4% |
| 2024-09-30 → 2024-12-31 | -9.1% | +2.1% |
| 2024-12-31 → 2025-03-31 | -12.7% | -4.6% |
| 2025-03-31 → 2025-06-30 | +4.6% | +10.5% |
| 2025-06-30 → 2025-09-30 | +30.6% | +7.8% |
| 2025-09-30 → 2025-12-31 | +37.5% | +2.4% |
| 2025-12-31 → 2026-03-31 | -0.5% | -4.6% |
| 2026-03-31 → 2026-06-30 | +24.0% | +14.8% |
| 2026-06-30 → 2026-09-30 | -8.3% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LP